Three Questions For FDA
June 24, 2008
After listening to last week’s press conferences by the FDA and CDC, three questions came to mind: 1) Why does the FDA establish policies that
After listening to last week’s press conferences by the FDA and CDC, three questions came to mind: 1) Why does the FDA establish policies that
Over the weekend we came out with a Special Announcement entitled, FDA Expands List of Mexican States Not Associated With Salmonella Saintpaul Outbreak, and we
One wonders if the FDA is aware of how much its rhetoric has diverged from its practice. On a recent press call, Dr. David Acheson,
It is no surprise, but in a recent conference call Dr. David Acheson, M.D., FDA’s Associate Commissioner for Foods, finally fessed up to the way
If you listen to the pronouncements of the FDA, you see them as heroes searching with great difficulty to trace back the Salmonella outbreak on
Perhaps our biggest Pundit Peeve with this whole Salmonella Saintpaul/Tomato problem has been the lack of clarity with which CDC and FDA chooses to communicate
The FDA and CDC have held a series of conference calls and press conferences during the Salmonella Saintpaul outbreak and most are rather predictable. Yet
The FDA has expanded its list of places in Mexico that “HAVE NOT BEEN ASSOCIATED WITH THE OUTBREAK” to including the following Mexican states: Aguascalientes,
A hat tip to Dan Cohen of Maccabee Seed Co. for sending along a USA Today article by Elizabeth Weise that we think is a
As one looks at the numbers, one wonders if this is actually a single outbreak. Right from the beginning, there was something curious about this
